Biology of Blood and Marrow Transplantation
Volume 12, Issue 1 , Pages 1-30 , January 2006

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Adults: An Evidence-based Review

  • Theresa Hahn

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • Corresponding Author InformationCorrespondence and reprint requests: Theresa Hahn, PhD, Roswell Park Cancer Institute, Medicine, Elm and Carlton Sts, Buffalo, NY 14263.
    • ,
  • Donna Wall

      Affiliations

    • Texas Transplant Institute, San Antonio, Texas
    • ,
  • Bruce Camitta

      Affiliations

    • Midwest Children’s Center, Medical College of Wisconsin and Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Stella Davies

      Affiliations

    • Cincinnati Children’s Hospital and Medical Center, Cincinnati, Ohio
    • ,
  • Hildy Dillon

      Affiliations

    • The Leukemia and Lymphoma Society, White Plains, New York
    • ,
  • Paul Gaynon

      Affiliations

    • Children’s Hospital of Los Angeles, Los Angeles, California
    • ,
  • Richard A. Larson

      Affiliations

    • University of Chicago, Chicago, Illinois
    • ,
  • Susan Parsons

      Affiliations

    • Tufts-New England Medical Center, Boston, Massachusetts
    • ,
  • Jerome Seidenfeld

      Affiliations

    • Blue Cross and Blue Shield Association Technology Evaluation Center, Chicago, Illinois
    • ,
  • Daniel Weisdorf

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota
    • ,
  • Philip L. McCarthy Jr

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York

Received 18 October 2005 ,Accepted 19 October 2005.

References 

  1. Hahn T , Wolff SN , Czuczman MC , et al.   The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma (an evidence-based review) . Biol Blood Marrow Transplant . 2001;7:308–331
  2. Hahn T , Wingard J , Anderson K , et al.   The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma (an evidence-based review) . Biol Blood Marrow Transplant . 2003;9:4–37
  3. Hahn T , Wall D , Camitta B , et al.   The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children (an evidence-based review) . Biol Blood Marrow Transplant. . 2005;11:823–861
  4. Jones R , Nieto Y , Rizzo JD , et al.   The evolution of the evidence-based review (evaluating the science enhances the art of medicine–statement of the steering committee for evidence-based reviews of the American Society for Blood and Marrow Transplantation) . Biol Blood Marrow Transplant. . 2005;11:819–822
  5. Fiere D , Lepage E , Sebban C , et al.   Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia . J Clin Oncol . 1993;11:1990–2001
  6. Sebban C , Lepage E , Vernant JP , et al.   Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia . J Clin Oncol . 1994;12:2580–2587
  7. Thomas X , Boiron JM , Huguet F , et al.   Outcome of treatment in adults with acute lymphoblastic leukemia (analysis of the LALA-94 trial) . J Clin Oncol . 2004;22:4075–4086
  8. Dombret H , Gabert J , Boiron JM , et al.   Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia–results of the prospective multicenter LALA-94 trial . Blood . 2002;100:2357–2366
  9. Zhang MJ , Hoelzer D , Horowitz M , et al.  The Acute Lymphoblastic Leukemia Working Committee   Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation . Ann Intern Med . 1995;123:428–431
  10. Horowitz MM , Messerer D , Hoelzer D , et al.   Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission . Ann Intern Med . 1991;115:13–18
  11. Messerer D , Neiss A , Horowitz MM , et al.   Comparison of chemotherapy and bone marrow transplants using two independent clinical databases . J Clin Epidemiol . 1994;47:1119–1126
  12. Oh H , Gale RP , Zhang MJ , et al.   Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission . Bone Marrow Transplant . 1998;22:253–257
  13. Messerer D , Neiss A , Aydemir U , et al.   How can disease-free survival of adult ALL patients with or without transplants be compared? . Onkologie . 1991;14:53–55
  14. Takeuchi J , Kyo T , Naito K , et al.   Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia (the JALSG-ALL93 study) . Leukemia . 2002;16:1259–1266
  15. Gupta V , Yi QL , Brandwein J , et al.   The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission (a donor vs no donor comparison) . Bone Marrow Transplant . 2004;33:397–404
  16. Ueda T , Miyawaki S , Asou N , et al.   Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy (the ALL90 study of the Japan Adult Leukemia Study Group) . Int J Hematol . 1998;68:279–289
  17. Tamura S , Takemoto Y , Kanamaru A , et al.   Comparison of the survivals between bone marrow transplantation and chemotherapy for acute leukemia in first remission–a Japanese single institution study . Leuk Lymphoma . 1992;8:361–364
  18. Powles R , Mehta J , Singhal S , et al.   Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission (50 cases from a single center) . Bone Marrow Transplant . 1995;16:241–247
  19. Tiley C , Powles R , Treleaven J , et al.   Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukemia . Bone Marrow Transplant . 1993;12:449–455
  20. Mehta J , Powles R , Singhal S , et al.   Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission . Bone Marrow Transplant . 1996;18(suppl 1):119–123
  21. Lambertenghi Deliliers G , Mozzana R , Annaloro C , et al.   Long-term results of autologous bone marrow transplantation in adult acute lymphoblastic leukemia . Leuk Lymphoma . 1993;11:419–425
  22. Carey PJ , Proctor SJ , Taylor P , et al.  The Northern Regional Bone Marrow Transplant Group   Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation . Blood . 1991;77:1593–1598
  23. Proctor SJ , Taylor P , Thompson RB , et al.   Acute lymphoblastic leukemia in the northern region of England–a study of 75 cases . Q J Med . 1985;57:761
  24. Abdallah A , Egerer G , Goldschmidt H , et al.   Continuous complete remission in adult patients with acute lymphocytic leukemia at a median observation of 12 years after autologous bone marrow transplantation . Br J Haematol . 2001;112:1012–1015
  25. Hoelzer D , Thiel E , Loffler H , et al.   Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults . Blood . 1988;71:123–131
  26. Gilmore MJ , Hamon MD , Prentice HG , et al.   Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukemia in first complete remission . Bone Marrow Transplant . 1991;8:19–26
  27. Mehta J , Powles R , Treleaven J , et al.   Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia (long-term follow-up) . Leuk Lymphoma . 1997;25:479–486
  28. Doney K , Buckner CD , Fisher L , et al.   Autologous bone marrow transplantation for acute lymphoblastic leukemia . Bone Marrow Transplant . 1993;12:315–321
  29. Hill RS , Mazza P , Amos D , et al.   Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation . Bone Marrow Transplant . 1989;4:69–74
  30. Ringden O , Labopin M , Bacigalupo A , et al.   Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia . J Clin Oncol . 2002;20:4655–4664
  31. Passweg JR , Tiberghien P , Cahn JY , et al.   Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia . Bone Marrow Transplant . 1998;21:153–158
  32. Frassoni F , Labopin M , Gluckman E , et al.   Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time–a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT) . Bone Marrow Transplant . 1996;17:13–18
  33. Ringden O , Labopin M , Gluckman E , et al.  Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation   Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis . Bone Marrow Transplant . 1996;18:921–929
  34. Randolph SSB , Gooley TA , Warren EH , et al.   Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants . Blood . 2004;103:347–352
  35. Gale RP , Horowitz MM , Ash RC , et al.   Identical-twin bone marrow transplants for leukemia . Ann Intern Med . 1994;120:646–652
  36. Barrett AJ , Horowitz MM , Ash RC , et al.   Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia . Blood . 1992;79:3067–3070
  37. Chao NJ , Forman SJ , Schmidt GM , et al.   Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission . Blood . 1991;78:1923–1927
  38. Deconinck E , Cahn JY , Milpied N , et al.   Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission (long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)) . Bone Marrow Transplant . 1997;20:731–735
  39. Biggs JC , Horowitz MM , Gale RP , et al.   Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy . Blood . 1992;80:1090–1093
  40. Snyder DS , Chao NJ , Amylon MD , et al.   Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission . Blood . 1993;82:2920–2928
  41. Jamieson CHM , Amylon MD , Wong RM , et al.   Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide (a 15-year experience) . Exp Hematol . 2003;31:981–986
  42. Lee S , Kim DW , Cho B , et al.   Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukemia in remission treated with allogeneic bone marrow transplantation (the potential of real-time quantitative reverse-transcription polymerase chain reaction) . Br J Haematol . 2003;120:145–153
  43. Horowitz MM , Gale RP , Barrett AJ , et al.   Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukemia. International Bone Marrow Transplant Registry . Lancet . 1989;1:535–537
  44. Kumar S , Chen MG , Gastineau DA , et al.   Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia . Leukemia . 2003;17:1865–1870
  45. von Bueltzingsloewen A , Belanger R , Perreault C , et al.   Allogeneic bone marrow transplantation following busulfan-cyclophosphamide with or without etoposide conditioning regimen for patients with acute lymphoblastic leukemia . Br J Haematol . 1993;85:706–713
  46. Blume KG , Forman SJ , Snyder DS , et al.   Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission . Transplantation . 1987;43:389–392
  47. McCarthy DM , Barrett AJ , MacDonald D , et al.   Bone marrow transplantation for adults and children with poor risk acute lymphoblastic leukemia in first complete remission . Bone Marrow Transplant . 1988;3:315–322
  48. De la Camara R , Figuera A , Steegmann JL , et al.   Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia. Results from a single institution . Bone Marrow Transplant . 1992;9:433–438
  49. Au WY , Lie AK , Ma SK , et al.   Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia (a single-centre experience) . Hematol Oncol . 1998;16:163–168
  50. Atkinson K , Biggs JC , Concannon A , et al.   The impact of leukemia status at the time of HLA-identical sibling marrow transplantation on subsequent complication rate and survival of adults with acute leukemia . Aust N Z J Med . 1986;16:462–469
  51. Aversa F , Terenzi A , Carotti A , et al.   Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia . J Clin Oncol . 1999;17:1545–1550
  52. Snyder DS , Nademanee AP , O’Donnell MR , et al.   Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission . Leukemia . 1999;13:2053–2058
  53. Cornelissen JJ , Carston M , Kollman C , et al.   Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia (strong graft-versus-leukemia effect and risk factors determining outcome) . Blood . 2001;97:1572–1577
  54. Gaderet L , Labopin M , Gorin NC , et al.   Patients with acute lymphoblastic leukemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow . Bone Marrow Transplant . 2003;31:23–29
  55. Sierra J , Radich J , Hansen JA , et al.   Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia . Blood . 1997;90:1410–1414
  56. Kiehl MG , Kraut L , Schwerdtfeger R , et al.   Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia (no difference in related compared with unrelated transplant in first complete remission) . J Clin Oncol . 2004;22:2816–2825
  57. Cahn JY , Labopin M , Schattenberg A , et al.   Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT) . Leukemia . 1997;11:416–419
  58. Doney K , Hägglund H , Leisenring W , et al.   Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia . Biol Blood Marrow Transplant . 2003;9:472–481
  59. Esprou H , Boiron JM , Cayuela JM , et al.   A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (results from the French Bone Marrow Transplantation Society) . Bone Marrow Transplant . 2003;31:909–918
  60. Stirewalt DL , Guthrie KA , Beppu L , et al.   Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation . Biol Blood Marrow Transplant . 2003;9:206–212
  61. Iida H , Sao H , Kitaori K , et al.   Twenty years’ experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group . Int J Hematol . 2004;79:79–84
  62. Lee S , Kim DW , Kim YJ , et al.   Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B-lineage acute lymphoblastic leukemia in first or second remission . Br J Haematol . 2002;117:109–118
  63. Wassmann B , Pfeifer H , Scheuring U , et al.   Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) . Leukemia . 2002;16:2358–2365
  64. Martino R , Giralt S , Caballero MD , et al.   Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia (a feasibility study) . Haematologica . 2003;88:555–560
  65. Arnold R , Massenkeil G , Bornhäuser M , et al.   Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease . Leukemia . 2002;16:2423–2428
  66. Hunault M , Harousseau JL , Delain M , et al.   Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT (a GOELAMS trial) . Blood . 2004;104:3028–3037
  67. Attal M , Blaise D , Marit G , et al.  BGMT Group   Consolidation treatment of adult acute lymphoblastic leukemia (a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation) . Blood . 1995;86:1619–1628
  68. Ringden O , Labopin M , Gorin NC , et al.   Is there a graft-versus-leukemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukemia? . Br J Haematol . 2000;111:1130–1137
  69. Sotomayor EM , Piantadosi S , Miller CB , et al.   Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia (impact of induction Ara-C dose and post-remission therapy) . Leukemia Res . 2002;26:461–471
  70. Annaloro C , Curioni ACE , Molteni M , et al.   Hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia (a single-center analysis) . Leuk Lymphoma . 2004;45:1175–1180
  71. Vey N , Blaise D , Stoppa AM , et al.   Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission . Bone Marrow Transplant . 1994;14:383–388
  72. Blaise D , Gaspard MH , Stoppa AM , et al.   Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission . Bone Marrow Transplant . 1990;5:7–12
  73. Soiffer RJ , Roy DC , Gonin R , et al.   Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse . Bone Marrow Transplant . 1993;12:243–251
  74. Ifrah N , Witz F , Jouet JP , et al.  GOELAMS Group   Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia . Cancer . 1999;86:1496–1505
  75. Kroger N , Kruger W , Wacker-Backhaus G , et al.   Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia . Bone Marrow Transplant . 1998;22:1029–1033
  76. Stockschlader M , Hegewisch-Becker S , Kruger W , et al.   Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia . Bone Marrow Transplant . 1995;16:663–667
  77. Martino R , Bellido M , Brunet S , et al.   Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia (results of a prospective trial) . Haematologica . 1999;84:505–510
  78. Martino R , Bellido M , Brunet S , et al.   Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia . Bone Marrow Transplant . 1998;21:1023–1027
  79. Dunlop LC , Powles R , Singhal S , et al.   Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia . Bone Marrow Transplant . 1996;17:365–369
  80. Goldstone AH , Lazarus HJ , Richards SM , et al.   The outcome of 551 1st CR transplants in adult ALL from the UKALL XII/ECOG 2993 study . [abstract] Blood . 2004;104:178a
  81. Lazarus HM , Richards SM , Chopra R , et al.   Adult patients with acute lymphoblastic leukemia (ALL) and central nervous system (CNS) leukemia at diagnosis may attain durab le complete remissions (CR). Results from the International ALL Trial (MRC UKALL-XII/ECOG E2993) . [abstract] Blood . 2004;104:204b
  82. Goldstone AH , Chopra R , Buck G , et al.   The outcome of 267 Philadelphia positive adults in the International UKALL12/ECOG E2993 study. Final analysis and the role of allogeneic transplant in those under 50 years . [abstract] Blood . 2003;102:80a
  83. Ries LAG, Eisner MP, Kosary CL, et al. Surveillance, Epidemiology and End Results Cancer Statistics Review, 1975-2002, National Cancer Institute, Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2002/. Accessed June 6, 2005.

 All terms abbreviated in this article are defined in a Glossary of Terms, Appendix A, at the end of the article.

PII: S1083-8791(05)00718-4

doi: 10.1016/j.bbmt.2005.10.018

Biology of Blood and Marrow Transplantation
Volume 12, Issue 1 , Pages 1-30 , January 2006

Article Tools

* Image Usage & Resolution